celecoxib has been researched along with Airway Hyper-Responsiveness in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD." | 1.72 | Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study. ( Çakmak, ME, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Çakmak, ME | 1 |
| Valero, A | 1 |
| Enrique, E | 1 |
| Baltasar, M | 1 |
| Cisteró, A | 1 |
| Martí, E | 1 |
| Picado, C | 1 |
1 trial available for celecoxib and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
[Celecoxib in NSAID-induced cutaneous and respiratory adverse reactions].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Eru | 2003 |
1 other study available for celecoxib and Airway Hyper-Responsiveness
| Article | Year |
|---|---|
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitor | 2022 |